Application of PET and PET/CT imaging for cancer screening

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 4103-4108

  Chen, Yen Kung ^a   Ding, Hueisch Jy ^a   Su, Chen Tau ^b   Shen, Yeh You ^a   Chen, Liang Kuang ^b   Liao, Alfred C ^a   Hung, Tzu Zin ^a   Hu, Feng Lan ^a   Kao, Chia Hung ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cancer screening; FDG; PET; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TUMOR MARKER; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BRAIN; CANCER; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DRUG UPTAKE; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; URINARY TRACT CANCER; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NEOPLASM; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING;

ADULT; AGED; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 14944343855     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Henschke CI, McCauley DI, Yankelevitz DF et al: Early lung cancer action project: overall design and findings from baseline screening. Lancet 354: 99-105, 1999.
2. Brant-Zawadzki M: CT screening: why I do it. AJR 179: 319-326, 2002.
3. Dixon GD: Computed tomography for screening purposes: a review of the literature-2003. Mo Med 100: 140-144, 2003.
4. Ko JSC, Cheng HC, Chang HY and Chang CY: Whole-body MR imaging: the future "X ray"? AJR 180: 860-861, 2003.
5. Gambhir SS, Czernin J, Schwimmer J et al: A tabulated summary of the FDG PET literature. J Nucl Med 42: 1S-93S, 2001.
6. Yasuda S, Ide M, Fujii H et al: Application of positron emission tomography imaging to cancer screening. Br J Cancer 83: 1607-1611, 2000.
7. Shen YY, Su CT, Chen GJ et al: The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening. Neoplasma 50: 217-221, 2003.
8. Webb WR, Gatsonis C, Zerhouni EA et al: CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 178: 705-713, 1991.
9. Durdey P, Weston PMT and Williams NS: Colonoscopy or barium enema as initial investigation of colonic disease. Lancet 2: 549-551, 1987.
10. Mukai M, Sadahiro S, Yasuda S et al: Preoperative evaluation by whole-body 18F-fluorodeoxyglucose positron emission tomography in patients with primary colorectal cancer. Oncol Rep 7: 85-87, 2000.
11. Falk PM, Gupta NC, Thorson AG et al: Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 37: 153-156, 1994.
12. Abdel-Nabi H, Doerr RJ, Lamonica DM et al: Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose wholebody PET: correlation with histopathologic and CT findings. Radiology 206: 755-760, 1998.
13. Delbeke D: Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med 40: 591-603, 1999.
14. Drenth JP, Nagengast FM and Oyen WJ: Evaluation of (pre-) malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med 28: 1766-1769, 2001.
15. Tabar L: Control of breast cancer through screening mammography. Radiology 174: 655-656, 1990.
16. Nystrom L, Rutqvist LE, Wall S et al: Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 341: 973-978, 1993.
17. Eckhardt S, Badellino F and Murphy GP: UICC meeting on breast cancer screening in premenopausal women in developed countries. Int J Cancer 56: 1-5, 1994.
18. Noh DY, Yun IJ, Kim JS et al: Diagnostic value of positron emission tomography for detecting breast cancer. World J Surg 22: 223-228, 1998.
19. Yutani K, Hojo S, Tatsumi M et al: Correlation of F-18-FDG and Tc-99m-MIBI uptake with proliferative activity in breast cancer. J Nucl Med 40: 16P-17P, 1999.
20. Sone S, Li F, Yang ZG et al: Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 84: 25-32, 2001.
21. Li F, Sone S, Abe H et al: Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings. Radiology 225: 673-683, 2002.